Mechanistically, our results indicated that PRKDC could interact with ZBTB38 and repress the function of ZBTB38. Knocking down PRKDC could promote DKK1 expression to suppress the malignant progression of prostate cancer cells. Here, DKK1 is linked to prostate carcinoma.